pranolol tafla 40 mg
actavis group ptc ehf. - propranololum hýdróklóríð - tafla - 40 mg
pranolol tafla 80 mg
actavis group ptc ehf. - propranololum hýdróklóríð - tafla - 80 mg
atenolol mylan filmuhúðuð tafla 50 mg
viatris limited - atenololum inn - filmuhúðuð tafla - 50 mg
atenolol mylan filmuhúðuð tafla 25 mg
viatris limited - atenololum inn - filmuhúðuð tafla - 25 mg
hemangiol
pierre fabre medicament - própranólól hýdróklóríð - hemangioma - betablokkar - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
peratsin húðuð tafla 2 mg
orion corporation - perphenazinum inn - húðuð tafla - 2 mg
peratsin húðuð tafla 4 mg
orion corporation - perphenazinum inn - húðuð tafla - 4 mg
peratsin húðuð tafla 8 mg
orion corporation - perphenazinum inn - húðuð tafla - 8 mg
adrenalin mylan stungulyf, lausn 1 mg/ml
viatris limited - adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 1 mg/ml
maxalt smelt frostþurrkuð tafla 10 mg
n.v. organon* - rizatriptanum benzóat - frostþurrkuð tafla - 10 mg